Epimedium polysaccharide improves T cell immune mediation by increasing the number of CD3+ and CD4+ cells and the ratio of CD4+/CD8+, thereby enhancing immune function and reducing hematologic toxicity in mice with benzene-induced bone marrow failure [41]. The gene discussed is CD4; the disease is Bone marrow hypocellularity.